Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Sergey Terushkin, MD, FACS Board-Certified Physician Metabolic & Weight Management Specialist This article is for educational purposes only and does not replace medical advice
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity
Alternatives might include switching to a different GLP-1 medication (some patients tolerate one better than another despite similar mechanisms), reducing the maintenance dose to a level that produces fewer GI effects while still providing benefit, or transitioning to tirzepatide or another agent in the class
:max_bytes(150000):strip_icc():focal(749x0:751x2)/oatzempic-040124-5-c01290c2c2d8468c9fcfa1195527e52a.jpg)
It is recommended that semaglutide for weight loss be accompanied by exercise and dietary changes
Those using tirzepatide were much more likely to return to normal blood glucose levels at 72 weeks, with 87.5% estimated to reach normoglycemia, compared with 76.88% for those receiving semaglutide
US$ 25.74
US$ 29.41
US$ 25.03
US$ 24.46
